|
Published by: CCM International Limited
Published: Nov. 21, 2008 - 116 Pages
Table of Contents
- Executive summary
- Introduction and methodologies
- I Review of PAP & paracetamol industry
- I1 Brief introduction to paracetamol industry in China
- I2 Brief introduction to PAP industry in China
- II Brief introduction to various technologies of PAP and paracetamol
- II1 Introduction to processes for PAP production
- II1.1 Industralized technologies of PAP in China
- Iron reduction of pnitrophenol
- Catalytic hydrogenation of pnitrophenol
- Catalytic hydrogenation of nitrobenzene
- II1.2 Technologies under research
- Electrolytic reduction of nitrobenzene
- Other findings
- II1.3 Comparison among the above four technologies
- II2 Introduction to processes for paracetamol production
- II2.1 Onestep method
- II2.2 Twostep method
- III Detailed introduction to most popular methods of PAP and paracetamol
- III1 Technology for PAP
- III1.1 Description of production process and theoretical model of raw materials by iron reduction technology
- III1.2 Description of production process and theoretical model of raw materials by nitrobenzene catalytic hydrogenation technology
- III2 Technology for paracetamol
- III2.1 Brief description of production process
- III2.2 Flow chart of paracetamol production
- III2.3 Theoretical model of raw materials
- IV Estimation on cost and profit of PAP and paracetamol
- IV1 In PAP enterprises
- IV1.1 Jiangsu Zhongming (adopting PNCB technology)
- Basic situation in Jiangsu Zhongming
- Financial analysis of Jiangsu Zhongming in 2007
- Estimation on raw material cost
- Estimation on manufacturing cost
- Estimation on management cost
- Estimation on tatal production cost
- Estimation on profit
- IV1.2 Liaoning Tianbao (adopting PNCB technology)
- Basic situation in Liaoning Tianbao
- Financial analysis of Liaoning Tianbao in 2007
- Estimation on raw material cost
- Estimation on manufacturing cost
- Estimation on management cost
- Estimation on profit
- IV1.3 Liaoning Jinhuaiadopting NB technologyj
- Basic situation in Huludao Jinhu
- Estimation on raw material cost
- Estimation on manufacturing cost
- Estimation on management cost
- Estimation on profit
- IV1.4 Comparison among above three manufacturers
- IV2 In paracetamol enterprises
- IV2.1 Hebei Jiheng
- Basic situation in Hebei Jiheng
- Actual flowchart in Hebei Jiheng
- Financial analysis of Hebei Jiheng in 2007
- Estimation on raw material cost
- Estimation on manufacturing cost
- Estimation on management cost
- Estimation on total production cost
- Estimation on profit
- IV2.2 Lufan Pharm
- Basic situation in Lufan Pharm
- Financial analysis of Lufan Pharm in 2007
- Estimation on raw material cost
- Estimation on manufacturing cost
- Estimation on management cost
- Estimation on total production cost
- Estimation on profit
- IV2.3 Comparison between Hebei Jiheng and Lufan Pharm in profit
- V Forecast on PAP & paracetamol industry in China
- V1 Forecast on market
- V2 Forecast on technology
- V3 Competitive power of Chinese paracetamol
- VI Site Visit Reports
- LIST OF TABLES
- Table 1 Production situation of Chinese PAP producers, Nov2008
- Table 2 RMB/USD exchange rates, 19942008
- Table I11 Output of NSAIDs in China in 2007
- Table I12 Output, export, import and domestic consumption of paracetamol in China, 1998~2007
- Table I13 Average export price of Chinese paracetamol in 2007 and JanAug. 2008
- Table I21 Export of Chinese PAP, 2000~2007
- Table II11 Major technologies of PAP production in China, 2008
- Table II12 Technologies adopted by overseas PAP producers
- Table II13 Production situation of Chinese PAP producers, Oct2008
- Table II1.21 Main patents on catalytic hydrogenation of nitrobenzene, 20042008
- Table II1.3 1 Comparison among different technologies, Oct2008
- Table II2.31 Key researchers on paracetamol in China
- Table III1.11 Theoretical consumption of raw material of PAP in China, Oct2008
- Table III1.21 Theoretical consumption of raw material of PAP in China, Oct2008
- Table III2.31 Theoretical estimation on raw material costs of paracetamol
- Table IV1.11 Main equipment in Jiangsu Zhongming
- Table IV1.12 General situation of Jiangsu Zhongming, Oct2008
- Table IV1.13 Balance sheet of Jiangsu Zhongming in 2007
- Table IV1.14 Income statement of Jiangsu Zhongming in 2007
- Table IV1.15 Cash flow statement of Jiangsu Zhongming in 2007
- Table IV1.16 Financial analysis of Jiangsu Zhongming in 2007
- Table IV1.17 Raw material costs of PAP in Jiangsu Zhongming in Oct2008
- Table IV1.18 Estimation on manufacturing costs of PAP production in Jiangsu Zhongming, Oct2008
- Table IV1.19 Estimation on management cost of Jiangsu Zhongming in Oct2008
- Table IV1.110 Estimation on total production costs in Jiangsu Zhongming, Oct2008
- Table IV1.111 Tax ratio in China
- Table IV1.112 Estimation on profit of Jiangsu Zhongming, Oct2008
- Table IV1.21 List of main sets of equipment in Liaoning Tianbao, Oct2008
- Table IV1.22 General situation of Liaoning Tianbao
- Table IV1.23 Balance sheet of Liaoning Tianbao in 2007
- Table IV1.24 Income statement of Liaoning Tianbao in 2007
- Table IV1.25 Cash flow statement of Liaoning Tianbao in 2007
- Table IV1.26 Financial analysis of Liaoning Tianbao in 2007
- Table IV1.27 Raw material costs of PAP in Liaoning Tianbao in Oct2008
- Table IV1.28 Estimation on manufacturing costs of PAP production in Liaoning Tianbao, Oct2008
- Table IV1.29 Estimation on management cost of Jiangsu Zhongming, Oct2008
- Table IV1.210 Estimation on profit of Liaoning Tianbao, Oct2008
- Table IV1.31 Estimation on raw material cost of PAP in Liaoning Jinhua, Oct2008
- Table IV1.32 Estimation on manufacturing costs of PAP production in Liaoning Jinhua, Oct2008
- Table IV1.33 Estimation on management cost of Liaoning Jinhua, Oct2008
- Table IV1.34 Estimation on profit of Liaoning Jinhua
- Table IV1.41 Comparison of cost between Jiangsu Zhongming and Liaoning Tianbao, Oct2008
- Table IV1.42 Comparison of income and profit between Jiangsu Zhongming and Liaoning Tianbao, Oct2008
- Table IV1.43 Comparison of cost and profit between Jiangsu Zhongming, Liaoning Tianbao and Liaoning Jinhua, Oct2008
- Table IV2.11 Balance sheet of Hebei Jiheng in 2007
- Table IV2.12 Income statement of Hebei Jiheng in 2007
- Table IV2.13 Cash flow statement of Hebei Jiheng in 2007
- Table IV2.14 Financial analysis of Hebei Jiheng in 2007
- Table IV2.15 Estimation on raw material costs of paracetamol in Hebei Jiheng
- Table IV2.16 Manufacturing costs of paracetamol production in Hebei Jiheng
- Table IV2.17 Estimation on management cost of Hebei Jiheng
- Table IV2.18 Estimation of total production cost in Hebei Jiheng
- Table IV2.19 The profit estimation of paracetamol in Hebei Jiheng
- Table IV2.21 Balance sheet of Lufan Pharm in 2007
- Table IV2.22 Income statement of Lufan Pharm in 2007
- Table IV2.23 Cash flow statement of Lufan Pharm in 2007
- Table IV2.24 Financial analysis of Lufan Pharm in 2007
- Table IV2.25 Estimation on raw material costs of paracetamol in Lufan Pharm
- Table IV2.26 Manufacturing costs of paracetamol production in Lufan Pharm
- Table IV2.27 Estimation on management cost of Lufan Pharm
- Table IV2.28 Estimation of total production cost in Lufan Pharm
- Table IV2.29 The profit estimation of paracetamol in Lufan Pharm
- Table IV2.31 Comparison between Hebei Jiheng and Lufan Pharm in Oct 2008
- Table V21 Estimation on future technology structure of PAP in China, tonnes, 20082015
- Table V31 SWOT analysis of the top five paracetamol manufacturers in China
- Table VI11 List of main equipment of PAP production in Jiangsu Zhongming
- Table VI12 PAP specification in Jiangsu Zhongming
- Table VI21 List of main equipments in Liaoning Tianbao
- Table VI22 PAP specification in Liaoning Tianbao
- Table VI31 Equipments affiliated to 3,000 t/a PAP production line in Liaoning Tiancheng
- LIST OF FIGURES
- Figure1 Forecast on technology structure of PAP in China, 20082015
- Figure I11 Market share of main NSAIDs in China in 2007
- Figure I12 Export situation to different destinations of Chinese paracetamol, 2003~2007
- Figure 113 Average export price of Chinese paracetamol, 1999~2007
- Figure I21 Output of PAP in China, 1998~2007
- Figure I22 Export volume and price of PAP produced by different process in China, 2000~2007
- Figure I23 Consumption structure of PAP in China, 2007
- Figure V21 Forecast on technology structure of PAP in China, 20082015, by output volume
- Figure V22 Forecast on technology structure of PAP in China, 20082015, by output share
AbstractThe consumption of paracetamol, which takes the most important position among NSAIDs, has kept growing worldwide, which promotes the production of PAP, the key raw material of paracetamol.
As one of main paracetamol manufacturers in the world, China's paracetamol export has constituted 30%-40% of the total paracetamol consumed in the world. On the other hand, process of PAP and paracetamol in China is improving, largely attributable to the governmental environmental protection policy.
However, China’s PAP manufacturers’ profit has been further squeezed by the growing investment in environmental protection and the global economic depression in 2008.
To further penetrate into the industry, especially the production process, CCM has produced a report of Benchmarking on PAP and Paracetamol Production in China, which will provide you with the answers to the following questions:
- What are the developing status and trends of the production processes of PAP and paracetamol in China?
- What are the production costs of these process by theoretical model?
- What are the actual production cost and total profit of benchmark enterprises of PAP and paracetamol in this report in China?
- How are the total profit comparison between benchmark enterprises of PAP and paracetamol?
- What are the financial analysis of benchmark enterprises in 2007?
- What are the prospective technologies of PAP production in China till 2015?
Get Full Details About This Report >>
|
|
US: 800.298.5699
Int'l: +1.240.747.3093
|
|
|
|
About MarketResearch.com
MarketResearch.com is an online aggregator selling over 250,000 market research reports, company profiles and country profiles from over 650 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.
© MarketResearch.com 2009
|